Tag: Calquence
AstraZeneca to acquire TeneoTwo
AstraZeneca is all geared up to buy US-based biotech firm, TeneoTwo in a deal valued at around US$1.27 billion. The development aligns with the...
AstraZeneca’s Calquence shows promising clinical improvement in Covid-19 patients
Results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor, reduced markers of inflammation and improved clinical outcomes of...